In conclusion, our results strongly suggest that different events taking place in the inflammatory hallmark of atherosclerosis conduct to a pro-amyloidogenic processing of apoA-I which in turn could impair the vascular disease. This evidence concerns the gene APOA1 and atherosclerosis.